Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Nonadherence to Antiretroviral Therapy Among People Living with HIV/AIDS Attending Two Tertiary Care Hospitals in District of Northern India.

Shukla M, Agarwal M, Singh JV, Tripathi AK, Srivastava AK, Singh VK.

Indian J Community Med. 2016 Jan-Mar;41(1):55-61. doi: 10.4103/0970-0218.170970.

2.

Antiretroviral drug diversion links social vulnerability to poor medication adherence in substance abusing populations.

Tsuyuki K, Surratt HL.

AIDS Behav. 2015 May;19(5):869-81. doi: 10.1007/s10461-014-0969-7.

3.

Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?

Magidson JF, Listhaus A, Seitz-Brown CJ, Safren SA, Lejuez CW, Daughters SB.

J Behav Med. 2015 Apr;38(2):337-47. doi: 10.1007/s10865-014-9606-1. Epub 2014 Nov 9.

4.

Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV.

Feldman BJ, Fredericksen RJ, Crane PK, Safren SA, Mugavero MJ, Willig JH, Simoni JM, Wilson IB, Saag MS, Kitahata MM, Crane HM.

AIDS Behav. 2013 Jan;17(1):307-18. doi: 10.1007/s10461-012-0326-7.

5.

The HIV Medication Taking Self-efficacy Scale: psychometric evaluation.

Erlen JA, Cha ES, Kim KH, Caruthers D, Sereika SM.

J Adv Nurs. 2010 Nov;66(11):2560-72. doi: 10.1111/j.1365-2648.2010.05400.x. Epub 2010 Aug 16.

6.

Relationship between non-specific prescription pill adherence and ischemic stroke outcomes.

Ovbiagele B, Campbell S, Faiz A, Chambless LE; VISP Study Investigators.

Cerebrovasc Dis. 2010 Jan;29(2):146-53. doi: 10.1159/000262311. Epub 2009 Dec 1.

7.

Alcohol use and antiretroviral adherence: review and meta-analysis.

Hendershot CS, Stoner SA, Pantalone DW, Simoni JM.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180-202. doi: 10.1097/QAI.0b013e3181b18b6e. Review.

8.

A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.

Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.

AIDS Patient Care STDS. 2009 Aug;23(8):593-601. doi: 10.1089/apc.2009.0021.

9.

Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.

Heffelfinger JD, Voetsch AC, Nakamura GV, Sullivan PS, McNaghten AD, Huang L.

PLoS One. 2009;4(3):e5002. doi: 10.1371/journal.pone.0005002. Epub 2009 Mar 25.

10.

Behavioral indices in medical care outcome: the working alliance, adherence, and related factors.

Fuertes JN, Boylan LS, Fontanella JA.

J Gen Intern Med. 2009 Jan;24(1):80-5. doi: 10.1007/s11606-008-0841-4. Epub 2008 Oct 30.

11.

The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

J Pediatr Psychol. 2009 Mar;34(2):164-75. doi: 10.1093/jpepsy/jsn068. Epub 2008 Jul 22.

12.

Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature.

Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G.

Retrovirology. 2008 Feb 1;5:13. doi: 10.1186/1742-4690-5-13. Review.

13.

The impact of medication regimen factors on adherence to chronic treatment: a review of literature.

Ingersoll KS, Cohen J.

J Behav Med. 2008 Jun;31(3):213-24. doi: 10.1007/s10865-007-9147-y. Epub 2008 Jan 19. Review.

14.

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C.

PLoS Med. 2006 Nov;3(11):e438. Review.

15.

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA.

AIDS Behav. 2006 May;10(3):227-45. Review.

17.

Gender differences in factors associated with adherence to antiretroviral therapy.

Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH.

J Gen Intern Med. 2004 Nov;19(11):1111-7.

18.

Improving adherence to HAART.

Stone VE, Smith KY.

J Natl Med Assoc. 2004 Feb;96(2 Suppl):27S-29S. Review. No abstract available.

19.
20.

Prevention and treatment of hepatitis C in injection drug users.

Edlin BR.

Hepatology. 2002 Nov;36(5 Suppl 1):S210-9. Review.

Supplemental Content

Support Center